ENTEROBIOTIX LIMITED – MIA(IMP) 49464
| Authorisation Number | UK MIA(IMP) 49464 |
| Category | MIA(IMP) |
| Holder | ENTEROBIOTIX LIMITED |
| Registered Address | ENTEROBIOTIX LIMITED, PHOENIX HOUSE, STRATHCLYDE BUSINESS PARK, BELLSHILL, ML4 3NJ, UNITED KINGDOM |
| Authorisation Date | Feb 13, 2026 |
| Legal Basis | InvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031] |
| Sites | 1 |
| Manufacturing Operations | 1.2 1.2.1 1.2.1.1 1.2.1.15 1.2.2 1.3 1.3.1 1.3.1.6 1.3.1.8 1.3.2 1.3.2.6 1.3.2.8 1.5 1.5.1 1.5.1.1 1.6 1.6.2 1.6.3 1.6.4 |
| MHRA Link | View on MHRA Website |
Sites (1)
ENTEROBIOTIX LIMITED
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.15 — Other non-sterile medicinal products
1.2.2 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.6 — Human or animal extracted products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.6 — Human or animal extracted products
1.3.2.8 — Other biological medicinal products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Content Preview
The source document is available on KeyPedia. Sign in to view.